scispace - formally typeset
C

Charles C. DeCarli

Researcher at University of California, Davis

Publications -  9
Citations -  1105

Charles C. DeCarli is an academic researcher from University of California, Davis. The author has contributed to research in topics: Hyperintensity & Genome-wide association study. The author has an hindex of 9, co-authored 9 publications receiving 984 citations. Previous affiliations of Charles C. DeCarli include Rush University Medical Center & Centre Hospitalier Universitaire de Bordeaux.

Papers
More filters
Journal ArticleDOI

Novel genetic loci associated with hippocampal volume

Derrek P. Hibar, +432 more
TL;DR: It is shown that genetic variants associated with decreased hippocampal volume are also associated with increased risk for Alzheimer's disease (rg=−0.155), and these findings suggest novel biological pathways through which human genetic variation influences hippocampus volume and risk for neuropsychiatric illness.
Journal ArticleDOI

Cognitive Impact of Subcortical Vascular and Alzheimer’s Disease Pathology

TL;DR: To assess the interactions among three types of pathology (ie, cerebrovascular disease, hippocampal sclerosis [HS], and Alzheimer's disease [AD]), cognitive status, and apolipoprotein E genotype, data are analyzed on mice with hippocampus-based dementia.
Journal ArticleDOI

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases

Giovanni Coppola, +211 more
TL;DR: These data provide the first genetic evidence and functional studies supporting the role of MAPT p.A152T as a rare risk factor for both FTD-s and AD and the concept that rare variants can increase the risk for relatively common, complex neurodegenerative diseases is suggested.
Journal ArticleDOI

Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI

Benjamin F.J. Verhaaren, +107 more
TL;DR: A meta-analysis of multiethnic genome-wide association studies identified 4 novel genetic loci that implicate inflammatory and glial proliferative pathways in the development of WMH in addition to previously proposed ischemic mechanisms.
Journal ArticleDOI

Vitamin B12, cognition, and brain MRI measures: a cross-sectional examination.

TL;DR: Methylmalonate, a specific marker of B12 deficiency, may affect cognition by reducing total brain volume whereas the effect of homocysteine (nonspecific to vitamin B 12 deficiency) on cognitive performance may be mediated through increased white matter hyperintensity and cerebral infarcts.